Key facts: United Kingdom
| Main buyers | National NHS commercial teams (the Commercial Medicines Unit) for hospital medicines; NHS Supply Chain for devices and consumables; NHS National Services Scotland; NHS Wales Shared Services Partnership |
|---|---|
| Main routes | National generics and biosimilar frameworks in waves, split by region; device frameworks |
| Typical term | Usually 12 to 24 months per wave, with start dates staggered by region |
| Award model | Price with service and supply criteria; England often multi-supplier per line by region, Scotland single or unranked multi-supplier |
How does the NHS buy hospital generics and biosimilars?
In England, the national generics programme runs in waves. Each wave sets the supplier and price per product line for a region, often with more than one supplier, and trusts buy against the framework. Scotland tenders its own national frameworks, usually per line with one supplier or an unranked group.
Outpatient generics are not tendered. Their reimbursement runs through the Drug Tariff, so the hospital frameworks are where suppliers compete head to head.
What changed with the Procurement Act 2023?
Procurements started on or after 24 February 2025 follow the Procurement Act 2023. Frameworks awarded before that date keep running under the old rules until they end, so both regimes are live for a while. The Act adds a contract details notice within 30 days of signing and, for contracts above £5 million, publication of the contract and its key performance indicators.
National NHS functions are also being reorganised into the Department of Health and Social Care, so buyer names may change. The frameworks themselves continue.
How does RGS help in the UK?
We follow the waves and frameworks across England, Scotland and Wales, record which suppliers were awarded each line and region, and keep the renewal calendar for your portfolio.
What is public in United Kingdom, and what is not
Tender notices, award notices, the names of the awarded suppliers and the estimated value of each framework are published.
Line-level award prices are not. They sit in confidential award schedules, and the volumes in tender packs are indicative.
Questions about United Kingdom
How does the NHS buy hospital generics and biosimilars?
In England through national frameworks tendered in waves, split by region and often with more than one supplier per line. Scotland and Wales run their own national procurement.
Are NHS framework prices published?
No. Award notices name the suppliers and the framework value, but line-level prices stay in confidential award schedules.
Can RGS show confidential contracts and prices in United Kingdom?
No outside service can, because they are never published. RGS covers what buyers publish. For the confidential part we set up a private pipeline for your company: your own bids, results, buyer correspondence and price lists, loaded next to the public data and visible only to your team.